Express Pharma
APRIL 6, 2025
Sun Pharmaceutical Industries (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715), along with its subsidiaries and associate companies, has announced the launch of Fexuprazan 40 mg tablets in India under the brand name FEXUCLUE. The drug, a potassium-competitive acid blocker (PCAB), has been approved for the treatment of all grades of Erosive Esophagitis in adults.
Pharmacy Joe
APRIL 6, 2025
In this episode, Ill discuss mannitol extravasation. Episode 1015: What To Do If Mannitol Extravasates Subscribe on iTunes , Android , or Stitcher When given as a bolus, mannitol is an osmotic diuretic that does not cross the blood-brain barrier. Mannitol lowers intracranial pressure by osmotically drawing free water out of the brain and into circulation where it can be eliminated.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaTech
APRIL 6, 2025
3D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.
Pharmacy Times
APRIL 6, 2025
Andrew Charles, MD, outlines why calcitonin-gene-related peptide (CGRP) antagonists are increasingly favored as first-line migraine treatments and how pharmacists play a key role in patient education and support.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Express Pharma
APRIL 6, 2025
At the recently held AD/PD 2025 International Conference on Alzheimers and Parkinsons Diseases (PD), Roche announced topline results of prasinezumab in patients with early Parkinsons disease (PD) on stable symptomatic treatment (PADOVA [NCT04777331]). The presentation highlighted the potential of prasinezumab at delaying PD motor progression as assessed with time-to-event endpoints, says GlobalData.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
FDA Law Blog: Biosimilars
APRIL 6, 2025
By Andrew J. Hull & David B. Clissold & Sophia R. Gaulkin & Esther Petrikovsky Last week, the Supreme Court issued a unanimous decision in FDA v. Wages & White Lion Investments, LLC , No. 23-1038 (Apr. 2, 2025) that affirms FDAs denial of authorization to market flavored vape products. This opinion, which overrules a Fifth Circuit decision that FDA had acted arbitrarily and capriciously in denying premarket tobacco product applications submitted by manufacturers of flavored e-li
Med Ed 101
APRIL 6, 2025
Deprescribing is an important part of care for hospice patients. The main goal of hospice care is to focus on comfort care rather than curative treatments, which means evaluating if a patients current medications are still indicated, effective, safe, and convenient. Some medications may no longer provide much benefit and could even cause harm or […] The post Deprescribing in Hospice – My Top 5 Targets appeared first on Med Ed 101.
FDA Law Blog: Biosimilars
APRIL 6, 2025
Hyman, Phelps & McNamara (HPM) marks its 45thAnniversary year by welcoming three accomplished professionals who reinforce the depth and breadth of the firms FDA and DEA practices. Naomi Lowy joins HPM as a Principal Drug Regulatory Expert after 18 years at the FDAs Center for Drug Evaluation and Research (CDER), most recently as the Deputy Director, Division of General Endocrinology.
STAT
APRIL 6, 2025
WASHINGTON — Health secretary Robert F. Kennedy Jr. said Sunday that “the most effective way to prevent the spread of measles is the MMR vaccine,” his most direct statement yet on the issue, following the death of a second child of the condition in the outbreak in West Texas. Kennedy, who has long described the vaccine as dangerous, has largely avoided endorsing its use since the start of the outbreak, and he stopped short of explicitly saying he “recommend
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Guardian - Pharmaceutical Industry
APRIL 6, 2025
The bosss bonus is an annual debating point at Britains biggest company. But thats not the only issue this year AstraZeneca is used to facing protests over pay at its annual general meetings, given the position of its chief executive, Pascal Soriot, as the best-paid FTSE 100 chief executive for most of the past five years. But pay is not the only issue overshadowing this years virtual gathering on Friday.
STAT
APRIL 6, 2025
The United States recorded three measles deaths in the first 24 years of this century. In just over three months of 2025, it has equaled that number. The most recent patient, an 8-year-old unvaccinated and previously healthy girl in West Texas, died late last week. Infectious disease experts warn that the days when measles deaths in the United States were ultra rare may be over for now.
STAT
APRIL 6, 2025
A second unvaccinated school-aged child in West Texas has died from a measles-related illness, a hospital spokesman confirmed Sunday, as the outbreak continues to swell. Aaron Davis, a spokesperson for UMC Health System in Lubbock, Texas, said that the child was “receiving treatment for complications of measles while hospitalized” and and did not have underlying health conditions.
Expert insights. Personalized for you.
59 
Let's personalize your content